Accretion Pharmaceuticals IPO Subscription
Accretion Pharmaceuticals IPO Subscription Status: 7.67x Times Highly Oversubscribed
Accretion Pharmaceuticals IPO is a Book Building issue of ₹29.75 Crore, offering about 29.46 Lakh to the public.
This IPO is a complete Fresh Issue of 29.46 Lakh crore shares worth ₹29.75 Crore crore.
Accretion Pharmaceuticals IPO Subscription Status: Highly Oversubscribed 7.67X Times
As of today, Accretion Pharmaceuticals IPO Subscription Status stands at 7.67X (Highly Oversubscribed). This says that the shares of Accretion Pharmaceuticals IPO have Very High Demand demand. We update the Accretion Pharmaceuticals IPO daily subscription trend. Investors should also check IPO GMP and Subject to Sauda rates for estimating listing gains.
| Category |
Day 1 14 May 2025 |
Day 2 15 May 2025 |
Day 3 16 May 2025 |
Subscription Status | Demand |
|---|---|---|---|---|---|
| Retail | 1.86 | 4.01 | 10.54 | Highly Oversubscribed | Very High Demand |
| NII | 0.51 | 0.92 | 4.28 | Oversubscribed | High Demand |
| QIB | 0.00 | 0.75 | 12.14 | Highly Oversubscribed | Very High Demand |
| Total | 1.12 | 2.37 | 7.67 | Highly Oversubscribed | Very High Demand |
- Retail: Retail Individual Investors or NRIs apply at range of ₹121,200 to ₹121,200.
- sNII: Small NIIs are investors who apply between ₹242,400 and ₹484,800.
- bNII: Big NIIs are investors who apply between ₹606,000 and ₹1,090,800.
- QIB: Qualified Institutional Buyers (FIIs, Mutual Funds, Banks) apply at ₹1,212,000 or more.
Accretion Pharmaceuticals Limited IPO (Accretion Pharmaceuticals IPO) Overview
| IPO Name | Accretion Pharmaceuticals Limited IPO |
| IPO Status | Listed on NSE at INR 79 (-21.78%) |
| IPO Open Date | 14 May 2025 |
| IPO Close Date | 16 May 2025 |
| Face Value | ₹10 Per Equity Share |
| One Lot Size | 1200 Equity Shares |
| Total Issue | 29,46,000 Shares (worth up to ₹29.75 Crore Rs) |
| Fresh Issue | 29,46,000 Shares (worth up to ₹29.75 Crore Rs) |
| Issue Type | Book Building Issue |
| IPO Listing | NSE EMERGE |
| Retail Portion | Up to 35% of Net Issue |
| NII Portion | Up to 15% of Net Issue |
| Net QIB Portion | Up to 20% of Net Issue |
| Anchor Portion | Up to 30% of Net Issue |
| DRHP Draft Prospectus | View DRHP |
| RHP Draft Prospectus | View RHP |
| Anchor Investors List | View List |
Accretion Pharmaceuticals IPO Important Dates
The following table gives all important events and their timelines for Accretion Pharmaceuticals IPO.
| Anchor Investors Bid Date | 13 May 2025 |
| IPO Open Date | 14 May 2025 |
| IPO Close Date and Time | 16 May 2025 at 3:15 PM |
| Basis of Allotment | 19 May 2025 at 9:00 PM |
| Refunds | 20 May 2025 |
| Credit to DEMAT | 20 May 2025 |
| IPO Listing Date | 21 May 2025 |
About Accretion Pharmaceuticals Limited Company
The Accretion Pharmaceuticals Limited company was founded in year 2012, by Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, Mr. Mayur Popatlal Sojitra and Mr. Hardik Mukundbhai Prajapati. They came together to establish a pharmaceutical manufacturing unit, with vision to provide health care products that match international quality standards at competitive pricing. The Company’s manufacturing facility is currently located in Ahmedabad, Sanand, Gujarat.
At present, the company is engaged in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), And Oral Powder (Sachet, Dry Syrup) etc. Apart from manufacturing products for direct sales, it also manufactures various pharmaceutical products for different marketers on loan license or contract manufacturing basis. Its business is majorly carried out on a principle-to-principle basis with different marketers.
Accretion Pharmaceuticals IPO Subscription Status FAQs
-
When is Accretion Pharmaceuticals IPO Subscription Start Date and End Date?
Accretion Pharmaceuticals IPO IPO Subscription status start date is 14 May 2025 and close date is 16 May 2025 at 3:15 PM.
-
What is the current Subscription Status of Accretion Pharmaceuticals IPO?
As of today, Accretion Pharmaceuticals IPO total subscription rate is 7.67×, Retail is subscribed 10.54×, NII is subscribed 4.28×, QIBs are subscribed 12.14×.
-
What is Accretion Pharmaceuticals IPO Reservation?
Out of 29.46 Lakh Crore shares, up to 35% (≈10.31 Crore) reserved for Retail, 15% (≈4.42 Crore) for NIIs, 20% (≈5.89 Crore) for QIBs, and % reserved for Employees.
-
How to check live Accretion Pharmaceuticals IPO Subscription today?
Please visit our Accretion Pharmaceuticals IPO Subscription. We update it hourly on our website.
-
Is Accretion Pharmaceuticals IPO oversubscribed or undersubscribed?
As of today, Accretion Pharmaceuticals IPO is subscribed 7.67× and it is Highly Oversubscribed.
-
What is the Demand status of Accretion Pharmaceuticals IPO Issue?
As per the Accretion Pharmaceuticals IPO subscription status 7.67×, demand is Very High Demand.